An Approximation of the Film Virus to the Pandemic of COVID-19

  • Lynn Francis Lau-Sánchez
    Universidad Privada Norbert Wiener, Lima lilianglican20[at]gmail.com
  • Karla Ximena Balcazar-Aniceto
    Universidad Privada Norbert Wiener, Lima
  • Jorge Porras-Guillermo
    Universidad Privada Norbert Wiener, Lima

Abstract

Through the years, science fiction cinema has become a repertoire of information that can be contrasted with reality. That is why we present the analysis of the film 'Virus' by Sung-su Kim, where the main objective is to present the film to the reader so that he can understand the pandemics represented through the films and compare it with the pandemic of the COVID-19 in an objective way, differentiating a cinematographic representation with reality. As an own elaboration, we present a table with the systemic manifestations of the COVID-19, made with reliable sources; with this we intend to seek the awareness and education of the reader about one of the worst pandemics we are currently going through. The conclusion is that the information given in the films related to health issues must be interpreted appropriately by the viewers, separating the real from the fictitious. On the other hand, COVID-19 is a disease that is still developing and there is increasing evidence of its systemic commitment.
  • Referencias
  • Cómo citar
  • Del mismo autor
  • Métricas
1. Legido-Quigley H, Mateos-García J, Campos V, Gea-Sánchez M, Muntaner C, McKee M. The resilience of the Spanish health system against the COVID-19 pandemic. Lancet Public Health. 2020;5(5):251-2.

2. Armocida B, Formenti B, Ussai S, Palestra F, Missoni E. Italian health system and the COVID-19 challenge. Lancet Public Health. 2020;5(5):253.

3. Zorroza M. Ficción, experiencia y realidad ¿Qué tiene que ver el cine con la vida? Revista de Comunicación. 2007;(6):70–80.

4. Ying-Hui J, Cai L, Zhen-Shun C, Cheng H, Deng T, Yi-Pin F, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia. Mil Med Res. 2020;7(4):1-23.

5. Lauer S, Grantz K, Bi Q, Jones F, Zheng Q, Meredith H, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020;172(9):577-82.

6. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2019;382:727–33.

7. Weiss S, Leibowitz J. Coronavirus pathogenesis. Adv Virus Res. 2011;81:85-164.

8. Richman D, Whitley R, Hayden F. Clinical virology. 4th ed. Washington: ASM Press; 2016.

9. Murray P, Rosenthal K, Pfaller M. Microbiología médica. 8th ed. Barcelona: Elsevier; 2017.

10. Yang D, Leibowitz J. The structure and functions of coronavirus genomic 3’ and 5’ends. Virus Res. 2015;206:120–33.

11. CDC. [Internet]. Enfermedad del coronavirus 2019 (COVID-19). Centers for Disease Control and Prevention. [Consultado el 28 de julio de 2020].

12. Docherty A, Harrison E, Green C, Hardwick H, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.

13. Pal R, Banerjee M. COVID-19 and the endocrine system: exploring the unexplored. J Endocrinol Invest. 2020;43(7):1027-31.

14. Zubair A, McAlpine L, Gardin T, Farhadian S, Kuruvilla D, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019. JAMA Neurol. 2020;77(8):1018-27.

15. Guzik T, Mohiddin S, Dimarco A, Patel V, Savvatis K, Marelli-Berg F, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 2020;116(10):1666-87.

16. Dhakal B, Sweitzer N, Indik J, Acharya D, William P. SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart Lung Circ. 2020;29(7):973-87.

17. Parra V, Flórez C, Romero-Sánchez M, García del Risco F. Síntomas gastrointestinales en la enfermedad por COVID-19 y sus implicaciones en enfermedad inflamatoria intestinal. Rev Colomb Gastroenterol. 2020;35(Supl.1):45-55.

18. Yang L, Tu L. Implications of gastrointestinal manifestations of COVID-19. Lancet Gastroenterol Hepatol. 2020;5(7):629-30.

19. Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;95(5):829-38.

20. Kissling S, Rotman S, Gerber C, Halfon M, Lamoth F, Comte D, et al. Collapsing glomerulopathy in a COVID-19 patient. Kidney Int. 2020;98(1):228-31.

21. Aiello F, Gallo Afflitto G, Mancino R, J-Peng L, Cesareo M, Giannini C, et al. Coronavirus disease 2019 (SARS-CoV-2) and colonization of ocular tissues and secretions: a systematic review. Eye. 2020;34:1206-11.

22. Wollina U, Karada? A, Rowland?Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID?19 patients: A review. Dermatol Ther. 2020;e13549.

23. Connors J, Levy J. COVID-19 and its implications for thrombosis and anticoagulation. Blood. 2020;135(23):2033-40.
Lau-Sánchez, L. F., Balcazar-Aniceto, K. X., & Porras-Guillermo, J. (2021). An Approximation of the Film Virus to the Pandemic of COVID-19. Journal of Medicine and Movies, 16(e), 379–388. https://doi.org/10.14201/rmc202016e379388

Downloads

Download data is not yet available.
+